SLC5A2 and type 2 diabetes mellitus: Canagliflozin, also known as Invokana, is a sodium‐glucose cotransporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus along with lifestyle changes including diet and exercise [50].